Company Filing History:
Years Active: 1992-1998
Title: The Innovative Mind of Subbiah Sangiah
Introduction: Subbiah Sangiah is a notable inventor based in Stillwater, Oklahoma, recognized for his contributions to the field of pharmaceuticals and chemical compounds. With a remarkable portfolio of four patents, his work primarily focuses on the development of multiclass antiarrhythmic agents, an area critical to managing heart conditions.
Latest Patents: Among his latest innovations, Sangiah has patented N-alkyl and N-acyl derivatives of 3,7-Diazabicyclo[3.3.1]nonanes, detailing various selected derivatives that hold promise as multiclass antiarrhythmic agents. These compounds, represented by the general formula, are particularly significant in addressing complex cardiac issues.
Career Highlights: Subbiah Sangiah has made a substantial impact during his tenure at Oklahoma State University and The Board of Regents of Oklahoma State University Physical Sciences. His research and inventions not only showcase his scientific prowess but also his commitment to advancing medical science through innovative solutions.
Collaborations: Throughout his career, Sangiah has collaborated with esteemed colleagues such as Kenneth D. Berlin and Benjamin J. Scherlag. Their collective efforts have significantly contributed to the field of pharmacological research and innovation, further amplifying the effectiveness and reach of their inventions.
Conclusion: With four patents to his name and a dedicated career in research and innovation, Subbiah Sangiah stands out as a leading figure in the realm of antiarrhythmic agents. His ongoing contributions are vital not just to the academic community but also to the healthcare industry, promising advancements in treatment options for patients around the world.